You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-FANCD2 antibody (ab2187)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-FANCD2 antibody
See all FANCD2 products (12) ...

Description

Rabbit polyclonal to FANCD2

Specificity

This antibody is specific for human FANC D2.

Tested applications

ICC/IF, WB, IPmore details

Cross reactivity

Reacts with

Mouse, Human

Immunogen

This antibody was made to an N-terminal fusion protein fragment (human).

Positive control

HeLa whole cell extracts.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.05% Sodium Azide
Constituents: Tris glycine, 150mM Sodium chloride

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - FANCD2 antibody (ab2187)Western blot - FANCD2 antibody (ab2187) image (enlarge)

  • Western blot - FANCD2 antibody (ab2187)Western blot - FANCD2 antibody (ab2187) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - FANCD2 antibody (ab2187)Immunocytochemistry/ Immunofluorescence - FANCD2 antibody (ab2187) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab2187 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Required for maintenance of chromosomal stability. Promotes accurate and efficient pairing of homologs during meiosis. Involved in the repair of DNA double-strand breaks, both by homologous recombination and single-strand annealing. May participate in S phase and G2 phase checkpoint activation upon DNA damage. Promotes BRCA2/FANCD1 loading onto damaged chromatin. May also be involved in B-cell immunoglobulin isotype switching.

Tissue specificity

Highly expressed in germinal center cells of the spleen, tonsil, and reactive lymph nodes, and in the proliferating basal layer of squamous epithelium of tonsil, esophagus, oropharynx, larynx and cervix. Expressed in cytotrophoblastic cells of the placenta and exocrine cells of the pancreas (at protein level). Highly expressed in testis, where expression is restricted to maturing spermatocytes.

Involvement in disease

Defects in FANCD2 are a cause of Fanconi anemia complementation group D type 2 (FANCD2) [MIM:227646]. It is a disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

Developmental stage

Highly expressed in fetal oocytes, and in hematopoietic cells of the fetal liver and bone marrow (at protein level).

Domain

The C-terminal 24 residues of isoform 2 are required for its function.

Post-translational
modifications

Monoubiquitinated on Lys-561 during S phase and upon genotoxic stress (isoform 1 and isoform 2). Deubiquitinated by USP1 as cells enter G2/M, or once DNA repair is completed. Monoubiquitination requires the FANCA-FANCB-FANCC-FANCE-FANCF-FANCG-FANCM complex, RPA1 and ATR, and is mediated by FANCL/PHF9. Ubiquitination is required for binding to chromatin, interaction with BRCA1, BRCA2 and MTMR15/FAN1, DNA repair, and normal cell cycle progression, but not for phosphorylation on Ser-222 or interaction with MEN1.
Phosphorylated in response to various genotoxic stresses by ATM and/or ATR. Upon ionizing radiation, phosphorylated by ATM on Ser-222 and Ser-1404. Phosphorylation on Ser-222 is required for S-phase checkpoint activation, but not for ubiquitination, foci formation, or DNA repair. In contrast, phosphorylation by ATR on other sites may be required for ubiquitination and foci formation.

Cellular localization

Nucleus. Concentrates in nuclear foci during S phase and upon genotoxic stress.

Target information above from: UniProt accessionQ9BXW9 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • DKFZp762A223 antibody
  • FA 4 antibody
  • FA D2 antibody
  • FA4 antibody
  • FAC D2 antibody
  • FACD 2 antibody
  • FACD antibody
  • FACD2 antibody
  • FACD2_HUMAN antibody
  • FAD antibody
  • FAD2 antibody
  • FANC D2 antibody
  • FANCD 2 antibody
  • FANCD antibody
  • FANCD2 antibody
  • FANCONI ANEMIA COMPLEMENTATION GROUP D antibody
  • Fanconi anemia complementation group D2 antibody
  • Fanconi anemia group D2 protein antibody
  • FANCONI PANCYTOPENIA TYPE 4 antibody
  • FLJ23826 antibody
  • OTTHUMP00000158853 antibody
  • OTTHUMP00000207925 antibody
  • Protein FACD2 antibody
  • Type 4 Fanconi pancytopenia antibody
see all

Anti-FANCD2 antibody images:

  Western blot - FANCD2 antibody (ab2187)

Western blot - FANCD2 antibody (ab2187)

All lanes : Anti-FANCD2 antibody (ab2187) at 1 µg/ml

Lane 1 : A431 (Human epithelial carcinoma cell line) Whole Cell Lysate (ab7909)
Lane 2 : Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate (ab7899)
Lane 3 : HEK293 Human embryonic kidney cell line Whole Cell Lysate (ab7902)

Lysates/proteins at 20 µg per lane.

Secondary
Goat polyclonal to Rabbit IgG (Alexa Fluor® 680) at 1/10000 dilution

Performed under reducing conditions.

Predicted band size : 166 kDa
Observed band size : 165 kDa (why is the actual band size different from the predicted?)

  Western blot - FANCD2 antibody (ab2187)

Western blot - FANCD2 antibody (ab2187)

All lanes : Anti-FANCD2 antibody (ab2187) at 1/1500 dilution

Lane 1 : Wild type human breast - whole cell lysate (positive control)
Lane 2 : Transient D2 Knockdown 24 hours after transfection - whole cell lysate
Lane 3 : Transient D2 Knockdown 48 hours after transfection - whole cell lysate
Lane 4 : Transient D2 Knockdown 120 hours after transfection - whole cell lysate

Secondary
Goat polyclonal Secondary Antibody to Rabbit IgA - alpha chain (ab2758) at 1/1500 dilution

Predicted band size : 166 kDa
Observed band size : 160 kDa (why is the actual band size different from the predicted?)

This image is courtesy of an Abreview submitted by Mr Richard Allum

See Abreview

  Immunocytochemistry/ Immunofluorescence - FANCD2 antibody (ab2187)

Immunocytochemistry/ Immunofluorescence - FANCD2 antibody (ab2187)

ab2187 at 1:500 staining FANCD2 in SiHa cells by ICC/IF. The proliferating SiHa cells were exposed to 10 Gy of IR and then double immunofluorescence staining was performed after 8 hours.

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - FANCD2 antibody (ab2187)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - FANCD2 antibody (ab2187)

ab2187 at 2.5µg/ml staining FANCD2 in human prostate glandular tissue section by Immunohistochemistry (Fromlain/ PFA fixed paraffin-embedded tissue sections).

References for Anti-FANCD2 antibody (ab2187)

This product has been referenced in:

  • Taniguchi Tet al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 9:568-74 (2003).Read more (PubMed: 12692539) »
  • Taniguchi Tet al. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100:2414-20 (2002).Read more (PubMed: 12239151) »

See all 19 publications for this product

Publishing research using ab2187? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"